Hangzhou, China

Biologics development and aseptic fill finish integrated facility

Hangzhou, China

Thermo Fisher’s new 80,000-square-meter current Good Manufacturing Practices (cGMP) facility offers integrated clinical and commercial drug substance and drug product capabilities, including process development, cell line development, biologics drug substance manufacturing and aseptic fill-finish.

Specialized Biologics Capabilities

Integrated drug substance and drug product manufacturing capabilities
In house analytical expertise, QC and QA
Expertise in fed batch and perfusion process
In house and partnered cell line development
Single use technologies and flexible facility design
Upstream & downstream process development expertise

Aseptic manufacturing and fill finish capabilities

Prefilled syringes
Prefilled cartridges
Sterile liquids injectable
Sterile lyophilized injectable
From clinical to commercial scale filling

Download fact sheet

Download visitor guide